A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/357 (2006.01) A61K 45/06 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2669123
The present invention relates to the use of ACAT inhibitors, {e.g. F-1394, Avasimibe (CI-1011), Pactimibe (CS505), Efluimibe (F12511), Eldacimibe, NTE 122, AS-183, KW-3033, E5324, FY087, FCE27677, CI-976, K-604, TEI6522, Octimibate, FR179254, and S 58-035, or mixtures thereof), compositions comprising the same, and methods for preventing or treating fibrosis, for preventing or reducing collagen deposition in a tissue, and in the prevention and reduction of excessive fibrous connective tissue
La présente invention porte sur l'utilisation d'inhibiteurs de ACAT (par exemple, F-1394, Avasimibe (CI-1011), Pactimibe (CS505), Efluimibe (F12511), Eldacimibe, NTE 122, AS-183, KW-3033, E5324, FY087, FCE27677, CI-976, K-604, TEI6522, Octimibate, FR179254 et S 58-035, ou des mélanges de ceux-ci), sur des compositions les contenant et sur des procédés pour la prévention ou le traitement de la fibrose, pour empêcher ou réduire le dépôt de collagène dans un tissu, et dans la prévention et la réduction d'un tissu conjonctif fibreux excessif.
Branicky Robyn S.
Hekimi Siegfried
Hihi Abdelmadjid K.
Jia Xihua
Chronogen Inc.
Robic
Sosei Co. Ltd.
LandOfFree
Acat inhibitors and their use in the prevention or treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acat inhibitors and their use in the prevention or treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acat inhibitors and their use in the prevention or treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1394812